Annual EBITDA
$1.16B$345.90M+42.30%
Summary
- Current Value
- As of today, DXCM annual EBITDA is $1.16B, up +42.30% on
- Historical Performance
- DXCM annual EBITDA is up +112.69% over the past 3 years, up +217.40% over the past 5 years
- All-Time High Comparison
- DXCM annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- DXCM annual EBITDA is +112.69% above its 3-year low of $547.10M reached on an earlier date
- Sector Comparison
- DXCM annual EBITDA is higher than 93.80% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $1.16B | +42.3% | +112.7% | +217.4% | +2815.3% | |
| Quarterly EBITDA | $322.40M | +66.4% | +263.1% | +382.6% | +3014.0% | |
| TTM EBITDA | $1.29B | +50.6% | +131.7% | +234.1% | +3081.6% | |
| Price | $71.44 | -18.2% | -39.0% | -17.0% | +1755.6% | |
| PE Ratio | 30.55 | -53.4% | -81.6% | -54.2% | – | |
| Annual Revenue | $4.66B | +15.6% | +60.2% | +142.0% | +9486.5% | |
| Annual EPS | $2.09 | +46.7% | +161.8% | +65.1% | +961.6% | |
| $911.80M | +52.0% | +133.1% | +204.4% | +2113.3% | ||
| Annual Net Income | $836.30M | +45.1% | +145.1% | +69.4% | +1615.9% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $1.16B | at high | |
| 5Y | $1.16B | at high | |
| All | $1.16B | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $547.10M | N/A | +112.7% |
| 5Y | $366.60M | N/A | +217.4% |
| All | -$151.80M | +866.5% |
EBITDA History
FAQ
What is the current annual EBITDA of DXCM?
As of today, DXCM annual EBITDA is $1.16B
What is 1-year change in DXCM annual EBITDA?
DXCM annual EBITDA is up +42.30% year-over-year
What is 3-year change in DXCM annual EBITDA?
DXCM annual EBITDA is up +112.69% over the past 3 years
How far is DXCM annual EBITDA from its all-time high?
DXCM annual EBITDA is currently at its all-time high
How does DXCM annual EBITDA rank versus sector peers?
DXCM annual EBITDA is higher than 93.80% of companies in Healthcare sector
When is DXCM next annual earnings release?
As of today, the next annual earnings release for DXCM has not been scheduled
Quarterly EBITDA
$322.40M$65.80M-16.95%
Summary
- Current Value
- As of today, DXCM quarterly EBITDA is $322.40M, down -16.95% on
- Historical Performance
- DXCM quarterly EBITDA is up +66.44% year-over-year, up +263.06% over the past 3 years
- All-Time High Comparison
- DXCM quarterly EBITDA is currently -16.95% below its historical high of $388.20M set on
- 3-Year Low Comparison
- DXCM quarterly EBITDA is +263.06% above its 3-year low of $88.80M reached on an earlier date
- Sector Comparison
- DXCM quarterly EBITDA is higher than 93.81% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $322.40M | -16.9% | +66.4% | +263.1% | +382.6% | |
| Annual EBITDA | $1.16B | – | +42.3% | +112.7% | +217.4% | |
| TTM EBITDA | $1.29B | +11.1% | +50.6% | +131.7% | +234.1% | |
| Price | $71.44 | -2.2% | -18.2% | -39.0% | -17.0% | |
| PE Ratio | 30.55 | -12.5% | -53.4% | -81.6% | -54.2% | |
| Quarterly Revenue | $1.19B | -5.4% | +15.1% | +60.7% | +136.0% | |
| Quarterly EPS | $0.51 | -24.4% | +92.2% | +325.8% | +267.3% | |
| $255.30M | -21.0% | +91.0% | +440.9% | +456.2% | ||
| Quarterly Net Income | $199.50M | -25.4% | +89.3% | +310.5% | +253.1% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $388.20M | -16.9% | |
| 3Y | $388.20M | -16.9% | |
| 5Y | $388.20M | -16.9% | |
| All | $388.20M | -16.9% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $193.70M | N/A | +66.4% |
| 3Y | $88.80M | N/A | +263.1% |
| 5Y | $32.70M | +885.9% | |
| All | -$156.00M | +306.7% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of DXCM?
As of today, DXCM quarterly EBITDA is $322.40M
What is DXCM quarterly EBITDA most recent change?
DXCM quarterly EBITDA was down -16.95% on March 31, 2026
What is 1-year change in DXCM quarterly EBITDA?
DXCM quarterly EBITDA is up +66.44% year-over-year
How far is DXCM quarterly EBITDA from its all-time high?
DXCM quarterly EBITDA is currently -16.95% below its historical high of $388.20M set on December 31, 2025
How does DXCM quarterly EBITDA rank versus sector peers?
DXCM quarterly EBITDA is higher than 93.81% of companies in Healthcare sector
When is DXCM next earnings release?
The next earnings release for DXCM is on
TTM EBITDA
$1.29B$128.70M+11.06%
Summary
- Current Value
- As of today, DXCM TTM EBITDA is $1.29B, up +11.06% on
- Historical Performance
- DXCM TTM EBITDA is up +50.65% year-over-year, up +131.68% over the past 3 years
- All-Time High Comparison
- DXCM TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- DXCM TTM EBITDA is +131.68% above its 3-year low of $557.80M reached on an earlier date
- Sector Comparison
- DXCM TTM EBITDA is higher than 93.81% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $1.29B | +11.1% | +50.6% | +131.7% | +234.1% | |
| Annual EBITDA | $1.16B | – | +42.3% | +112.7% | +217.4% | |
| Quarterly EBITDA | $322.40M | -16.9% | +66.4% | +263.1% | +382.6% | |
| Price | $71.44 | -2.2% | -18.2% | -39.0% | -17.0% | |
| PE Ratio | 30.55 | -12.5% | -53.4% | -81.6% | -54.2% | |
| TTM Revenue | $4.82B | +3.3% | +16.1% | +59.4% | +137.7% | |
| TTM EPS | $2.34 | +11.7% | +75.5% | +232.0% | +81.1% | |
| $1.03B | +13.3% | +63.4% | +160.2% | +231.4% | ||
| TTM Net Income | $930.40M | +11.3% | +73.8% | +218.1% | +75.5% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.29B | at high | |
| 3Y | $1.29B | at high | |
| 5Y | $1.29B | at high | |
| All | $1.29B | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $857.80M | N/A | +50.6% |
| 3Y | $557.80M | N/A | +131.7% |
| 5Y | $367.80M | +251.4% | |
| All | -$157.20M | +922.1% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of DXCM?
As of today, DXCM TTM EBITDA is $1.29B
What is DXCM TTM EBITDA most recent change?
DXCM TTM EBITDA was up +11.06% on March 31, 2026
What is 1-year change in DXCM TTM EBITDA?
DXCM TTM EBITDA is up +50.65% year-over-year
How far is DXCM TTM EBITDA from its all-time high?
DXCM TTM EBITDA is currently at its all-time high
How does DXCM TTM EBITDA rank versus sector peers?
DXCM TTM EBITDA is higher than 93.81% of companies in Healthcare sector
When is DXCM next earnings release?
The next earnings release for DXCM is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- DXCM Official Website www.dexcom.com/global
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1093557/000109355726000027/0001093557-26-000027-index.htm
- DXCM Profile on Yahoo Finance finance.yahoo.com/quote/DXCM
- DXCM Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dxcm